Jim Simons
TIL icon

Jim Simons’s Instil Bio TIL Stock Holding History

Jim Simons’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$487K Sell
59,100
-8,700
-13% -$70.6K ﹤0.01% 2608
2025
Q4 		$746K Buy
+67,800
New +$1M ﹤0.01% 2409
2025
Q3 		– Sell
-70,655
Closed -$1.47M – 3918
2025
Q2 		$1.47M Sell
70,655
-34,288
-33% -$717K ﹤0.01% 2300
2025
Q1 		$1.82M Sell
104,943
-28,812
-22% -$598K ﹤0.01% 2067
2024
Q4 		$2.55M Buy
133,755
+36,900
+38% +$1.13M ﹤0.01% 1890
2024
Q3 		$6.52M Sell
96,855
-19,400
-17% -$457K 0.01% 1281
2024
Q2 		$1.2M Sell
116,255
-10,000
-8% -$108K ﹤0.01% 2217
2024
Q1 		$1.36M Buy
126,255
+12,641
+11% +$139K ﹤0.01% 2282
2023
Q4 		$866K Buy
113,614
+61,343
+117% +$444K ﹤0.01% 2502
2023
Q3 		$447K Sell
52,271
-11,130
-18% -$112K ﹤0.01% 2756
2023
Q2 		$699K Buy
63,401
+22,535
+55% +$275K ﹤0.01% 2696
2023
Q1 		$540K Sell
40,866
-23,355
-36% -$345K ﹤0.01% 2847
2022
Q4 		$809K Buy
+64,221
New +$3.17M ﹤0.01% 2659
2022
Q3 		– Sell
-17,752
Closed -$1.64M – 4407
2022
Q2 		$1.64M Buy
+17,752
New +$2.51M ﹤0.01% 2341

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jim Simons's TIL Position: Q1 2026 in Review

Jim Simons reduced its Instil Bio (TIL) stake by 13% in Q1 2026, selling an estimated $70.6K and leaving 59,100 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Jim Simons first reported a position in TIL in Q2 2022 and has held it in 14 quarters since. The position peaked at $6.52M in Q3 2024. 32 funds tracked by Wall St. Rank hold TIL as of Q1 2026.

  • Jim Simons held 59,100 shares of Instil Bio worth $487K as of Q1 2026.
  • Jim Simons sold 8,700 Instil Bio shares in Q1 2026, an estimated $70.6K.
  • Instil Bio made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2608 holding.
  • Jim Simons first reported a position in Instil Bio in Q2 2022 and has held it in 14 quarters since.
  • Jim Simons's Instil Bio position peaked at $6.52M in Q3 2024.
  • 32 funds tracked by Wall St. Rank held Instil Bio as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.